Musical Training: Promoting Brain Function in Children Who Have Survived Brain Tumours
- Sponsor
- The Hong Kong Polytechnic University
- Study ID
- NCT07769099
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Brain Tumor
- Cancer Childhood
Eligibility Criteria
- Sex
- ALL
- Age
- 7 Years - 16 Years
- Healthy Volunteers
- Not accepted
Interventions
- Musical Training Program — OTHER52 weeks of musical training, consisting of (1) 36 weekly group based, face-to-face sessions, and (2) 16 weeks of weekly online individual sessions. Each lasting 45 minutes to 1 hour.
Study Details
This study aims to understand whether learning music can help improve brain function and quality of life in children who have recovered from brain tumours. A total of 236 children will join the study. Some of them will receive regular medical care, while others will take part in a music training program using the ukulele. The music program will last for one year and includes both in-person group classes and online individual sessions. The investigators will assess how well the children can think, remember, and focus before and after the training. The investigators will also ask about their daily life and well-being. This study hopes to show that music training can be a fun and helpful way to support recovery in childhood brain tumour survivors.
Key Dates
- First listed
- Aug 17, 2026
- Start date
- Oct 30, 2026
- Status verified
- Aug 2026
- Primary completion
- May 30, 2029
- Completion
- Oct 30, 2029
Study Design
- Enrollment
- 236 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Other: The intervention group will receive 52 weeks of musical training, including face-to-face and online.musical training
- No Intervention: ControlThe control group will receive usual care for 52 weeks
Primary Outcome Measure
Nonverbal Intelligence Score as Measured by the Test of Nonverbal Intelligence, Fourth Edition (TONI-4) [ Time Frame: At baseline, 12 months immediately after the completion of the intervention, and 6 months after the completion of the intervention ]
Central Contacts
- Joyce Chung+852 27666322
Find similar trials
Related Studies
- Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOAPHASE2 · Recruiting · Northwell Health · New York, New York
- Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed GlioblastomaPHASE1/PHASE2 · Recruiting · Northwell Health · New York, New York
- Study of Letrozole in Recurrent GliomasEARLY_PHASE1 · Recruiting · University of Cincinnati · Cincinnati, Ohio
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California